Buffy is an accomplished trial attorney who has handled cases in a wide range of practice areas, including product liability, toxic torts, environmental and natural resource damages, federal claims, project development litigation and internal investigations. She also counsels clients in the healthcare and life sciences industries on issues related to state and federal regulatory compliance, particularly those related to U.S. Food and Drug Administration rules. She has extensive experience in the defense of corporate clients in complex and mass tort litigation in both state and federal multidistrict proceedings.

Buffy also litigates parallel tort actions seeking personal injury, property and medical monitoring damages; she has successfully defended such cases whether filed by individual plaintiffs, as part of a mass tort, or as a class action. She manages and develops defense of product liability cases, analyzing ongoing litigation, coordinating the work of counsel across the country, selecting and preparing expert witnesses and deposing treating physicians. She has managed massive discovery efforts and handled class certification litigation in complex, multidefendant product liability cases.

Buffy also defends clients (including those in the healthcare industry and defense contractors) against qui tam actions filed under the False Claims Act, government investigations by the U.S. Department of Justice or other federal agencies, and in civil or criminal prosecutions brought by the U.S. Attorney.

She also handles commercial project development litigation, including multiparty construction-related disputes, breach of contract claims, delay claims, design/build AIA contract disputes, lease litigation and insurance coverage matters. She recently represented a District of Columbia-based commercial real estate developer in connection with a $25 million construction loan transaction, including drafting and negotiating the lease for a 40,000-plus square foot office building.

In her environmental practice, Buffy has handled complex litigation involving claims of natural resource damages and recovery claims related to one of the largest dredging projects in the country. She also advises clients regarding the defense of potential claims and the pursuit of potential contribution actions.

Before joining Shook, Buffy was a partner at Hollingsworth LLP in Washington, D.C., where she was instrumental in leading the firm to be selected as a finalist for the Minority Corporate Counsel Association's 2014 Thomas J. Sager Award. She devotes significant time to her community in pro bono service and working with civil justice organizations and the Board of Professional Responsibility of the D.C. Bar. 

Representative Matters

Quinteros, et al., v. DynCorp et al., No. 7-1042 (D.D.C., April 20, 2017). With a trial team partner, Buffy obtained a unanimous jury verdict finding no liability in tort in a case where six test plaintiffs claimed damages resulting from a herbicide used to spray illicit coca plants in the Republic of Colombia. 

Ezeb v. Sandoz Pharm. Corp., No. 1992-20622 (La. Civ. Dist. Ct., Orleans Parish, June 21, 2016). Buffy and a trial team partner persuaded the plaintiff to accept a settlement favorable to Sandoz on the last day of trial before closing arguments. The settlement finally ended the 26-year-old personal injury case, venued in an American Tort Reform Association-certified “judicial hellhole.” 

Earp v. Novartis Pharm. Corp., No. 11-680 (E.D.N.C., May 14, 2014). With a trial team partner, Buffy obtained a complete defense verdict following a finding by the jury that the alleged failure to provide an adequate warning or instruction regarding the use of chemotherapy drugs Zometa and Aredia wasn't the proximate cause of the plaintiff’s jaw injury.


Speaker, Disrupting the Mass Tort Industry, 22nd Annual Conference on Drug & Medical Device Litigation, New York City, December 6, 2017.

Panel Moderator, Inside View: Legal and Ethical Considerations for In-House Counsel, 4th Annual Life Sciences Legal Summit, San Francisco, California, September 14, 2017. 

Speaker, The Parallel Bars: Investigating Risks From, and Best Practices to Push Against, the Intense Surge in Parallel Proceedings, 27th Annual Seminar on Complex Litigation Defense, Washington, D.C., April 2015.

Panelist, Leave Humble Behind: Lead Your Cheering Section, Georgetown Law Women’s Forum, February 2015.

Panel Moderator, Subprime Lawsuits: Unbundling Baseless Claims in Serial Litigation, 26th Annual Seminar on Complex Litigation Defense, Washington, D.C., April 2014.

Speaker, Big Government in the Courtroom: Case Study of Westrick v. Second Chance Body Armor, et al., 25th Annual Seminar on Complex Litigation Defense, Washington, D.C., April 2013.

Speaker, Who Pays the Bills: “Loser Pays” and Cost-Shifting in E-Discovery, Daubert Proceedings and More, 24th Annual Seminar on Complex Litigation Defense, Washington, D.C., April 2012.

Panel Moderator, Persuading With Passion: Tips From the Top, Litigation Forum of the Women’s Bar Association, January 2012.


Shook Hardy Nabs Life Sciences Trial Pro From Hollingsworth, Law 360, August 10, 2017.

DynCorp Prevails in Ecuadorean Farmer's Herbicide Suit, Law360, April 21, 2017.

Law360 Product Liability Editorial Advisory Board, Law360, March 2, 2017.

10 Partners On the Secret Of Success, Law360, December 10, 2015.

And the Defense Wins, The Voice (DRI), August 26, 2015.

La. Appeals Court Backs Novartis in Schizophrenia Drug Suit, Law360, June 17, 2015. 

And the Defense Wins, The Voice (DRI), July 24, 2014.

Novartis Prevails in Bone Drug Trial in NC, Law360, May 14, 2014.

Novartis Gets Punitive Damages Barred in Bone Drug Suit, Law360, May 12, 2014.

Novartis Picks Up Win in Okla. Bone Drug Injury Suit, Law360, July 18, 2012.